ALBRIOZA Commercial Launch
PHOENIX is a Large, Global Phase 3 Clinical Trial in ALS
Designed to Support Global Regulatory Efforts and Continue to Provide Data on RELYVRIO
TRICALS
The highway towards a cure
W
UNIVERSITY of
WASHINGTON
SWEDISH
Sutter Health
CPMC
UC Irvine Health
Keck School of
Medicine of USC
BARROW
Neurological Institute
Hennepin Health
UMASS 3811
M Northwestern MedicinePenn
COLUMBIA UNIVERSITY
MEDICAL CENTER
RUTGERS
When we
Medicine School of Medicine
Feinberg School of Medicine
THE OHIO STATE UNIVERSITY
WEXNER MEDICAL CENTER
Health.
TEMPLE UNIVERSITY
JOHNS HOPKINS
MEDICINE
University of Colorado
Anschutz Medical Campus
Washington
University in St Louis
SCHOOL OF MEDICINE
TEXAS NEUROLOGY
ā
AUSTIN
NEUROMUSCULAR
CENTER
UNIVERSITY
NEUROSCIENCE
EMORY
UNIVERSITY
SCHOOL OF
MEDICINE
UFHealth
USF MORSANI
THE UNIVERSITY
of NORTH CAROLINA
at CHAPEL HILL
Wake Forest"
School of Medicine
NEALS
Northeast Amyotrophic
Lateral Sclerosis
Consortium
Note: 26 of the 28 PHOENIX sites in the U.S. are NEALS member sites.
ā AMYLYX 20View entire presentation